Changing concepts of pathophysiology, prognosis, and therapy in acute myocardial infarction.
Recent research findings regarding the pathophysiology of acute myocardial infarction, newer concepts of treatment, and better means of identifying high- and low-risk patients after acute myocardial infarction are presented, along with practical clinical considerations.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003327:Coronary Disease / Q000503:physiopathology; D003329:Coronary Vasospasm / Q000503:physiopathology; D003645:Death, Sudden; D004176:Dipyridamole / Q000627:therapeutic use; D006801:Humans; D008991:Monitoring, Physiologic; D009203:Myocardial Infarction / Q000188:drug therapy / Q000503:physiopathology*; D011379:Prognosis; D012008:Recurrence; D013442:Sulfinpyrazone / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone